vimarsana.com
Home
Live Updates
Zukunft der Pharmaindustrie – Roche baut das Gesch
Zukunft der Pharmaindustrie – Roche baut das Gesch
Zukunft der Pharmaindustrie – Roche baut das Geschäft mit dem Handel von Patientendaten aus
Der Basler Pharmakonzern Roche will das Sammeln und die Analyse von Patientinnendaten zu einem neuen Geschäfts-Standbein ausbauen.
Related Keywords
Zurich ,
Züsz ,
Switzerland ,
France ,
French ,
Swiss ,
,
Pharmaceutical Company ,
Group Boss Sex Appeal Swan ,
Approval Authority ,
Group For John ,
Cologne Journalist School ,
Basler Pharma Group ,
Pharmaceutical Industry ,
Patient Data ,
Business Segment ,
New Foothold ,
Christopher In French ,
Media Conference ,
Holger Published ,
Basler Pharma Giant ,
Data Analysis ,
Board Of Directors Christopher In French ,
Restricted Access ,
Sex Appeal Swan ,
Data Sets ,
Customer List ,
New Cancer Medicines ,
Data Volumes ,
Allows Conclusions ,
Such As Swan ,
Patient Data Ideas ,
New Therapy Approaches ,
New Studies ,
Pharmaceutical Industry Restricted Access ,
Real Terms ,
Data Collection ,
Billion Dollars ,
Complete Takeover ,
Million Revenue Both The Company ,
Million Dollars Revenue ,
New Drug ,
New Therapies ,
Study Results ,
Admission Authorities Industry Standards ,
Some New ,
Us Approval Authority ,
Chemical Industry ,
Working Priorities ,
German Handelsblatt ,
Clock Error ,